Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 1
2006 1
2009 1
2013 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Docetaxel and carboplatin as first-line chemotherapy in patients with advanced gynecological tumors. A phase I/II trial of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-OVAR) Ovarian Cancer Study Group.
Pfisterer J, du Bois A, Wagner U, Quaas J, Blohmer JU, Wallwiener D, Hilpert F; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-OVAR) Ovarian Cancer Study Group. Pfisterer J, et al. Gynecol Oncol. 2004 Mar;92(3):949-56. doi: 10.1016/j.ygyno.2003.12.004. Gynecol Oncol. 2004. PMID: 14984965 Clinical Trial.
[Hormone replacement therapy--a risk-benefit analysis].
Rabe T; Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) e. V; Deutsche Gesellschaft für Gynäkologische Endokrinologie und Fortpflanzungsmedizin (DGGEF) e. V; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO); Deutsche Menopause Gesellschaft (DMG); Deutsche Krebsgesellschaft (DKG); Deutsche Gesellschaft für Senologie, Berufsverband der Frauenärzte (BVF); Frauenärztliche Bundesakademie (FBA); World Society for Breast Health. Rabe T, et al. Zentralbl Gynakol. 2001 Jul;123(7):418-24. doi: 10.1055/s-2001-16864. Zentralbl Gynakol. 2001. PMID: 11534304 Review. German. No abstract available.
Phase II study of fulvestrant 250 mg/month in patients with recurrent or metastatic endometrial cancer: a study of the Arbeitsgemeinschaft Gynäkologische Onkologie.
Emons G, Günthert A, Thiel FC, Camara O, Strauss HG, Breitbach GP, Kölbl H, Reimer T, Finas D, Rensing K; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO). Emons G, et al. Gynecol Oncol. 2013 Jun;129(3):495-9. doi: 10.1016/j.ygyno.2013.02.039. Epub 2013 Mar 13. Gynecol Oncol. 2013. PMID: 23500091 Clinical Trial.
Phase I/II trial of multicycle high-dose chemotherapy with peripheral blood stem cell support for treatment of advanced ovarian cancer.
Frickhofen N, Berdel WE, Opri F, Haas R, Schneeweiss A, Sandherr M, Kuhn W, Hossfeld DK, Thomssen C, Heimpel H, Kreienberg R, Hinke A, Möbus V; German Study Groups Arbeitsgemeinschaft Internistische Onkologie (AIO); Arbeitsgemeinschaft Gynäkologische Onkologie (AGO). Frickhofen N, et al. Bone Marrow Transplant. 2006 Oct;38(7):493-9. doi: 10.1038/sj.bmt.1705472. Epub 2006 Aug 21. Bone Marrow Transplant. 2006. PMID: 16980997 Clinical Trial.